These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1151 related items for PubMed ID: 10204652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F, Julian JA, Kearon C.
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P, Simioni P, Pagnan A.
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [Abstract] [Full Text] [Related]

  • 7. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV.
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [Abstract] [Full Text] [Related]

  • 8. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
    Kearon C.
    Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
    [Abstract] [Full Text] [Related]

  • 9. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE.
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M, Desruennes E, Di Palma M.
    Bull Cancer; 2006 Mar 01; 93(3):271-81. PubMed ID: 16567314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV, CORTES Investigators. Clivarin: Assessment of Regression of Thrombosis, Efficacy, and Safety.
    N Engl J Med; 2001 Mar 01; 344(9):626-31. PubMed ID: 11228276
    [Abstract] [Full Text] [Related]

  • 14. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
    Hirsh J.
    Curr Opin Hematol; 1998 Sep 01; 5(5):360-5. PubMed ID: 9776217
    [Abstract] [Full Text] [Related]

  • 15. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
    Vardi M, Laor A, Bitterman H.
    Thromb Haemost; 2009 Nov 01; 102(5):879-86. PubMed ID: 19888523
    [Abstract] [Full Text] [Related]

  • 16. The optimal long-term treatment of venous thromboembolism.
    Prandoni P.
    Clin Adv Hematol Oncol; 2004 Nov 01; 2(11):729-32. PubMed ID: 16170889
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of venous thromboembolism.
    Raskob GE, Durica SS.
    Curr Opin Hematol; 1994 Sep 01; 1(5):329-35. PubMed ID: 9371301
    [Abstract] [Full Text] [Related]

  • 18. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.
    Matsagas MI.
    Int Angiol; 2004 Dec 01; 23(4):305-16. PubMed ID: 15767978
    [Abstract] [Full Text] [Related]

  • 19. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin.
    Harenberg J, Huisman MV, Tolle AR, Breddin HK, Kirchmaier CM.
    Semin Thromb Hemost; 2001 Oct 01; 27(5):513-8. PubMed ID: 11668421
    [Abstract] [Full Text] [Related]

  • 20. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE.
    Curr Opin Pulm Med; 1996 Jul 01; 2(4):305-10. PubMed ID: 9363157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.